Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001628280-21-024444

Options or other derivatives

  • Director acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Levy Caroline S Director 2021-12-01 Grant or award · Stock Option (right to buy) +40,000 40,000 D
Loading xslF345X03/wf-form4_163848152738878.xml…